Berylson Capital Partners’s GeneDx Holdings Warrant WGSWW Stock Holding History

Berylson Capital Partners’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-333,333	Closed	-$7.93K	–	25
2022 Q4	$6.33K	Hold	333,333	–	–	0.02%	19
2022 Q3	$76K	Hold	333,333	–	–	0.13%	23
2022 Q2	$108K	Hold	333,333	–	–	0.29%	20
2022 Q1	$230K	Hold	333,333	–	–	0.27%	30
2021 Q4	$327K	Hold	333,333	–	–	0.36%	25
2021 Q3	$707K	Buy	+333,333	New	+$1.1M	0.33%	27

Other funds holding WGSWW

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Berylson Capital Partners's WGSWW Position: Q1 2023 in Review

Berylson Capital Partners sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2023, closing a stake of 333,333 shares — an estimated $7.93K sold.

Berylson Capital Partners first reported a position in WGSWW in Q3 2021 and held it in 6 quarters. The position peaked at $707K in Q3 2021. 21 funds tracked by Wall St. Rank hold WGSWW as of Q1 2023.

Berylson Capital Partners reported no remaining GeneDx Holdings Warrant position as of Q1 2023 after selling out during the quarter.
Berylson Capital Partners sold 333,333 GeneDx Holdings Warrant shares in Q1 2023, an estimated $7.93K.
Berylson Capital Partners first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 6 quarters.
Berylson Capital Partners's GeneDx Holdings Warrant position peaked at $707K in Q3 2021.
21 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2023.

Based on Berylson Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.